Company page

Gri Bio, Inc.

Gri Bio, Inc. is a public company traded under the ticker GRI in the American market. With a market capitalization of approximately $3.33 million, Gri Bio focuses on biopharmaceutical development. The company is dedicated to advancing innovative therapies to address unmet medical needs.

profileGRI:NASDAQAI content: aiUpdated June 24, 2026/company/gri-bio-inc/c-8ybkuj1y
Gri Bio, Inc. logo
Ticker
GRI:NASDAQ
Asset type
Stock
Market cap
$3.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD